other Versions

Cognition enhancing drugs (‘nootropics’): time to include coaches and team executives in doping tests?
Compose Response

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g.
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Statement of Competing Interests


  • Responses are moderated before posting and publication is at the absolute discretion of BMJ, however they are not peer-reviewed
  • Once published, you will not have the right to remove or edit your response. Removal or editing of responses is at BMJ's absolute discretion
  • If patients could recognise themselves, or anyone else could recognise a patient from your description, please obtain the patient's written consent to publication and send them to the editorial office before submitting your response [Patient consent forms]
  • By submitting this response you are agreeing to our full [Response terms and requirements]
Publication Date - String

Vertical Tabs

Other responses

Jump to comment:

  • Published on:
    Quantitative Assessment of Cognitive Molecules Supplementary to Doping Test
    • Atif A Baig, Medical Researcher
    • Other Contributors:
      • Naveed MA

    Dear Editor,

    We have read the respective article, and we agreed to all stated observations and recommendations. This is a very useful article for many researchers and especially for the scientists working with addiction sciences.

    We would just like to emphasise on the use of quantitative assays for the cognitive molecules (Lee et al., 2009) beside doping test. Mental performance is the attribute of three...

    Show More
    Conflict of Interest:
    None declared.